Tahoe Therapeutics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 36

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $35M

  • Investors
  • 12

Tahoe Therapeutics General Information

Description

Operator of a biotech company intended to combine data to find better targets and drugs that can treat patients. The company's platform engages in generating scalable, single-cell precision to capture the context of disease at the first step of drug discovery and to better represent patient diversity in drug response over current in vitro assays, enabling doctors to improve the failure rate of drugs in clinical trials.

Contact Information

Formerly Known As
Vevo, Vevo Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 490 Forbes Boulevard
  • Suite 3B
  • South San Francisco, CA 94107
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 490 Forbes Boulevard
  • Suite 3B
  • South San Francisco, CA 94107
  • United States

Tahoe Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tahoe Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 11-Aug-2025 $35M Completed Generating Revenue
3. Seed Round Completed Generating Revenue
2. Accelerator/Incubator 01-May-2024 $12M Completed Generating Revenue
1. Seed Round 08-Dec-2022 $12M $12M Completed Generating Revenue
To view Tahoe Therapeutics’s complete valuation and funding history, request access »

Tahoe Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed-1
Seed 5,961,069 $0.000100 $2.06 $2.06 1x $2.06 17.72%
To view Tahoe Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Tahoe Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotech company intended to combine data to find better targets and drugs that can treat patients. The com
Drug Discovery
South San Francisco, CA
36 As of 2026

San Francisco, CA
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tahoe Therapeutics Competitors (2)

One of Tahoe Therapeutics’s 2 competitors is Numerion Labs, a Venture Capital-Backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Numerion Labs Venture Capital-Backed San Francisco, CA
insitro Venture Capital-Backed South San Francisco, CA
You’re viewing 2 of 2 competitors. Get the full list »

Tahoe Therapeutics Patents

Tahoe Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025090966-A1 Mek inhibitors, alone or in combination with cdk4/5 inhibitors, for use in treating cancer Inactive 26-Oct-2023

Tahoe Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tahoe Therapeutics Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Amplify Partners Venture Capital Minority
Civilization Ventures Venture Capital Minority
Conviction Partners Venture Capital Minority
Databricks Ventures Corporate Venture Capital Minority
Mubadala Investment Company Sovereign Wealth Fund Minority
You’re viewing 5 of 12 investors. Get the full list »

Tahoe Therapeutics Investments (1)

Tahoe Therapeutics’s most recent deal was a Joint Venture with Developing Antibody Drug (Alloy Therapeutics / Tahoe). The deal was made on 13-Jan-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Developing Antibody Drug (Alloy Therapeutics / Tahoe) 13-Jan-2026 Joint Venture Drug Discovery
To view Tahoe Therapeutics’s complete investments history, request access »

Tahoe Therapeutics FAQs

  • When was Tahoe Therapeutics founded?

    Tahoe Therapeutics was founded in 2022.

  • Where is Tahoe Therapeutics headquartered?

    Tahoe Therapeutics is headquartered in South San Francisco, CA.

  • What is the size of Tahoe Therapeutics?

    Tahoe Therapeutics has 36 total employees.

  • What industry is Tahoe Therapeutics in?

    Tahoe Therapeutics’s primary industry is Drug Discovery.

  • Is Tahoe Therapeutics a private or public company?

    Tahoe Therapeutics is a Private company.

  • What is the current valuation of Tahoe Therapeutics?

    The current valuation of Tahoe Therapeutics is .

  • What is Tahoe Therapeutics’s current revenue?

    The current revenue for Tahoe Therapeutics is .

  • How much funding has Tahoe Therapeutics raised over time?

    Tahoe Therapeutics has raised $50M.

  • Who are Tahoe Therapeutics’s investors?

    Amplify Partners, Civilization Ventures, Conviction Partners, Databricks Ventures, and Mubadala Investment Company are 5 of 12 investors who have invested in Tahoe Therapeutics.

  • Who are Tahoe Therapeutics’s competitors?

    Numerion Labs and insitro are competitors of Tahoe Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process